Cited by

• Evaluating Ligand Modifications of the Titanocene and Auranofin Moieties for the Development of More Potent Anticancer Drugs.

  Fernandez-Vega L, Ruiz Silva VA, Domínguez-González TM, Claudio-Betancourt S, Toro-Maldonado RE, Capre Maso LC, Ortiz KS, Pérez-Verdejo JA, González JR, Rosado-Fraticelli GT, Meléndez FP, Betancourt Santiago FM, Rivera-Rivera DA, Navarro CM, Bruno Chardón AC, Vera AO, Tinoco AD. Fernandez-Vega L, et al. Inorganics (Basel). 2020 Feb;8(2):10. doi: 10.3390/inorganics8020010. Epub 2020 Jan 26. Inorganics (Basel). 2020. PMID: 34046448 Free PMC article.
• Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocystine, a synergistic inhibitor of thioredoxin reductase.

  Liu C, Liu Z, Li M, Li X, Wong YS, Ngai SM, Zheng W, Zhang Y, Chen T. Liu C, et al. PLoS One. 2013;8(1):e53945. doi: 10.1371/journal.pone.0053945. Epub 2013 Jan 14. PLoS One. 2013. PMID: 23342042 Free PMC article.
• An effective strategy for the synthesis of biocompatible gold nanoparticles using cinnamon phytochemicals for phantom CT imaging and photoacoustic detection of cancerous cells.

  Chanda N, Shukla R, Zambre A, Mekapothula S, Kulkarni RR, Katti K, Bhattacharyya K, Fent GM, Casteel SW, Boote EJ, Viator JA, Upendran A, Kannan R, Katti KV. Chanda N, et al. Pharm Res. 2011 Feb;28(2):279-91. doi: 10.1007/s11095-010-0276-6. Epub 2010 Sep 25. Pharm Res. 2011. PMID: 20872051
• Synthesis and Structure-Activity Relationship Study of Antimicrobial Auranofin against ESKAPE Pathogens.

  Wu B, Yang X, Yan M. Wu B, et al. J Med Chem. 2019 Sep 12;62(17):7751-7768. doi: 10.1021/acs.jmedchem.9b00550. Epub 2019 Aug 21. J Med Chem. 2019. PMID: 31386365 Free PMC article.
• Inorganic Nanoparticles as Drug Delivery Systems and Their Potential Role in the Treatment of Chronic Myelogenous Leukaemia.

  Ghosn Y, Kamareddine MH, Tawk A, Elia C, El Mahmoud A, Terro K, El Harake N, El-Baba B, Makdessi J, Farhat S. Ghosn Y, et al. Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819853241. doi: 10.1177/1533033819853241. Technol Cancer Res Treat. 2019. PMID: 31138064 Free PMC article. Review.